NEUROTEC
ActiveSummary
NEUROTEC has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €531,407 and a net result of €1,740. Equity is growing by about 9% per year across the filed financial years. Its solvency ranks better than 57% of 5,004 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2025
20-10
NBB filing
Annual accounts filed
financial year 2025 · full format
31-03
Financial
Weakest financial yearnet €1,740 ▼28.6%
Net result drops to €1,740, the lowest in the series.
2024
30-10
NBB filing
Annual accounts filed
financial year 2024 · full format
2023
08-12
NBB filing
Annual accounts filed
financial year 2023 · full format · 38 days late
09-11
NBB filing
Annual accounts filed
financial year 2022 · full format · 374 days late
31-03
Financial
Equity above €500,000equity €527,228 ▲13.1%
A profit in every financial year since 2019 builds equity to €527,228.
2021
17-12
NBB filing
Annual accounts filed
financial year 2021 · full format · 47 days late
2020
30-11
NBB filing
Annual accounts filed
financial year 2020 · full format · 30 days late
31-03
Financial
Highest result from 2019 to 2025net €79,979 ▲58.1%
Operating result €145,525, net result €79,979, both a record.
2019
28-10
NBB filing
Annual accounts filed
financial year 2019 · full format
2018
29-10
NBB filing
Annual accounts filed
financial year 2018 · full format
2017
30-10
NBB filing
Annual accounts filed
financial year 2017 · full format
2016
27-09
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 34 annual accounts filed, the latest 10 are here; all 34 are under Financials.
0 of 7 deeds read
About the unread acts
We know of 7 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.